Statins use and prognosis in lung cancer patients treated with immune checkpoint inhibitors: evidence from a meta-analysis - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Impact of Statin Therapy on Outcomes in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: Insights from a Meta-Analysis

  • By

  • Dandan Liang

  • Qinghua Liu

  • Min Liu

  • Yi Li

  • September 1, 2026

Share

Original Source(s)

Statins use and prognosis in lung cancer patients treated with immune checkpoint inhibitors: evidence from a meta-analysis

  • by Dandan Liang, Qinghua Liu, Min Liu, Yi Li

  • September 1, 2026

Related Content

Cancer Communication in an Era of Fragmented Trust

Trastuzumab deruxtecan treatment for HER2-low metastatic scrotal extramammary Paget’s disease with bone marrow involvement: a case report

New Podcast Feature: Dr. Geoffrey Young on SurgOnc Today

Join Baptist Health's Dr. Geoffrey Young as he joins Drs. Sonia Cohen and Ashley Holder on the latest episode of SurgOnc Today.

  • by

  • August 28, 2026

  • 1 min